Agoraphobia and the Dexamethasone Suppression Test, Atypical Depression?

Whiteford, H. A. and Evans, Larry (1984) Agoraphobia and the Dexamethasone Suppression Test, Atypical Depression?. Australian and New Zealand Journal of Psychiatry, 18 4: 374-377.


Author Whiteford, H. A.
Evans, Larry
Title Agoraphobia and the Dexamethasone Suppression Test, Atypical Depression?
Journal name Australian and New Zealand Journal of Psychiatry
Publication date 1984
Sub-type Article
DOI 10.3109/00048678409158800
Volume number 18
Issue number 4
ISSN 0004-8674: 1440-1614
Start page 374
End page 377
Total pages 4
Place of publication Abingdon, England
Publisher Informa Healthcare
Language eng
Subject 110319 Psychiatry (incl. Psychotherapy)
Abstract The tricyclic antidepressants and the monoamine oxidase inhibitors have been shown to be effective in the treatment of some patients with phobic and panic disorders. To explain this action it has been suggested that a number of these patients may have an atypical biological depression. In an attempt to test this hypothesis we used the dexamethasone suppression test (DST), which has been proposed as a state dependent biological marker of depression. We compared the non-suppression rate of agoraphobic patients suffering panic attacks with controls and with patients suffering major depression. Twenty-nine per cent of the agoraphobics showed non-suppression compared with 12% of the control group and 64% of the depressives.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article
Collection: School of Population Health Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 12 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Access Statistics: 86 Abstract Views  -  Detailed Statistics
Created: Thu, 28 Aug 2008, 16:02:54 EST